Global Center on Adaptation and AUDA-NEPAD Sign Memorandum of Understanding to Accelerate Climate Change Adaptation in Africa

Rotterdam, June 14, 2024 (GLOBE NEWSWIRE) — The Global Center on Adaptation (GCA) and the African Union Development Agency (AUDA-NEPAD) signed a landmark memorandum of understanding (MoU) to collaborate on accelerating climate change adaptation efforts across Africa. Building on the AUC-GCA-AfDB Africa-led, Africa-owned Africa Adaptation Acceleration Program (AAAP), the partnership will support African member states to respond to the impact of the climate crisis.

The MoU establishes a framework for joint initiatives in such critical areas as access to climate adaptation finance, technical and institutional capacity building, climate-smart agriculture, sustainable land and water management, and disaster risk management inclusive the African Forest Landscape Restoration Initiative. The GCA and AUDA-NEPAD will also collaborate hand-in-hand to ensure full delivery on the $25 billion ambition of the AAAP by 2025 and to build the ground for even more ambitious follow-through beyond 2025.

Speaking at the signing ceremony at the GCA regional office in Rotterdam, GCA CEO Professor Patrick V. Verkooijen said: “We are delighted to formalize our collaboration with AUDA-NEPAD through this MoU. Together, we will work towards a climate-resilient Africa by leveraging our combined expertise and resources to support innovative climate adaptation actions on the ground. AAAP is the world’s largest climate adaptation program and the full delivery on the $25 billion ambition it by 2025 is crucial to keeping Africa safe from the escalating impacts of the climate crisis. This partnership is a significant step in our mission to accelerate climate adaptation solutions for Africa.”

Ms. Nardos Bekele-Thomas, CEO of AUDA-NEPAD said: “This MoU with the Global Center on Adaptation marks a pivotal moment in our efforts to build a resilient Africa. We are going to galvanize and double down on progress to fully deliver the Africa Adaptation Acceleration Program, as well as to take it to the next stages with the full engagement of Africa. By pooling our strengths, we will enhance the capacity of African countries to adapt to climate change, ensuring sustainable development and improved livelihoods for all. We look forward to a fruitful collaboration that will drive impactful adaptation initiatives across the continent.”

Key areas of cooperation outlined in the MoU include:

  1. Access to Climate Adaptation Finance: enhancing access to international climate finance for adaptation projects in Africa.
  2. Climate adaptation and training: providing capacity-building initiatives to strengthen adaptation planning and implementation at the local level.
  3. Institutional Support and collaboration: supporting the programmatic activities of the AUDA-NEPAD Centre on Climate Resilience and Adaptation.
  4. Climate-Smart Agriculture: promoting climate-smart technologies to improve agricultural productivity and food security.
  5. Sustainable Land and Water Management: scaling up nature-based practices to manage land degradation and drought.
  6. Building Resilience and Addressing Fragility and Food Insecurity in Rural Settings: mainstreaming climate adaptation jobs in youth-led enterprises with innovative climate adaptation and resilience solutions; and supporting access to digital advisory services and scalable investments for improved and resilient livelihoods linked to the energy-water-food nexus in rural areas.
  7. Support African Member States on Disaster Risk Management: increasing integration of disaster risk reduction in regional and national sustainable development frameworks and testing risk-informed preparedness plans.
  8. Support for African Forest Landscape Restoration Initiative: providing technical capacity to accelerate agroforestry investments to restore degraded landscapes and build resilient communities.
  9. Infrastructure Resilience: enhancing the resilience of infrastructure projects against climate impacts through capacity building and the identification of priority adaptation projects.

The GCA and AUDA-NEPAD will also jointly organize events and advocacy initiatives to promote climate adaptation. This includes participation in such continental and global climate forums as the United Nations Framework Convention on Climate Change (UNFCCC) Africa Climate Weeks and the GCA Annual Climate Adaptation Summit.

Notes to Editors
About the Global Center on Adaptation
The Global Center on Adaptation (GCA) is an international organization that promotes adaptation to the impacts of climate change. It works to climate-proof development by instigating policy reforms and influencing investments made by international financial institutions and the private sector. The goal is to bring climate adaptation to the forefront of the global fight against climate change and ensure that it remains prominent. Founded in 2018, GCA embodies innovation in its approach to climate adaptation as well as in its physical presence. It operates from the largest floating office in the world, in Rotterdam, the Netherlands. Together with the African Union Commission, the African Development Bank and partners, the GCA is spearheading the world’s largest adaptation program, the Africa Adaptation Acceleration Program (AAAP), which aims to shape $25 billion in climate proofed development investments by 2025. GCA has a worldwide network of regional offices in Abidjan, Côte d’Ivoire; Dhaka, Bangladesh; and Beijing, China. The GCA will open a new Africa Headquarters in Nairobi, Kenya in 2025.

About the African Union Development Agency
African Union Development Agency-NEPAD (AUDA-NEPAD) is the development agency of the African Union. It is mandated by the Assembly of Heads of State and Government to coordinate and execute priority regional and continental projects to promote regional integration towards the accelerated realization of Agenda 2063. Its other objectives are to strengthen the capacity of African Union Member States and regional bodies, advance knowledge-based advisory support, undertake the full range of resource mobilization and serve as the continent’s technical interface with all Africa’s development stakeholders and development partners.

Attachment

Alexandra Gee
Global Center on Adaptation
+447887804594
alex.gee@gca.org

GlobeNewswire Distribution ID 9154133

From Awareness to Action on Global Fatty Liver Day

Global Liver Institute Unites the Field in Times of Name Changes and New Treatments

WASHINGTON, June 13, 2024 (GLOBE NEWSWIRE) — Today marks the seventh annual Global Fatty Liver Day (formerly International NASH Day), led by Global Liver Institute (GLI) with the theme “Act Now, Screen Today.” This campaign underscores the crucial need for early identification and treatment of fatty liver disease to prevent its progression to chronic liver disease, cirrhosis, or cancer.

Fatty liver disease is now estimated to affect 1 in 3 adults worldwide, and its prevalence is increasing. Fatty liver disease during childhood, once unheard of, is also on the rise. Early detection and timely intervention, whether through lifestyle changes or medical treatments, are essential in stopping and even reversing the progression of the disease. “Act Now, Screen Today” emphasizes that liver health is achievable, but action must begin immediately. Across the globe, partners are driving awareness and educational efforts and ensuring broader access to essential screenings and care.

Global Fatty Liver Day, observed annually on the second Thursday of June, is a rallying cry for collective action to address the growing prevalence of fatty liver disease, the most common liver disease worldwide. “Act Now, Screen Today” reminds everyone that liver health is within reach. Here are specific actions you can take today:

  • Take advantage of liver health screening events happening globally to get assessed for fatty liver disease or schedule a check-up with your doctor, especially if you are managing closely associated metabolic conditions like obesity or diabetes
  • Increase physical activity, as maintaining an active lifestyle can improve liver health
  • Learn about fatty liver disease and its risk factors to take proactive steps towards prevention and management yourself or learn more about the latest research and guidelines for your patients.

With a robust pipeline of pharmaceutical treatments that address diverse mechanisms of action in progress, it is important to identify individuals’ position within the progression of fatty liver disease so that they are poised to receive the most appropriate care possible. Notably, pharmaceutical treatments are available (for certain groups with advanced disease) in two countries, the United States (resmetirom) and India (saroglitazar).

“As a community, we stand at a critical time for the broader global health system to act now to support patients,” shares Donna R. Cryer, JD, Founder and CEO of GLI. “As pharmaceutical treatment options gain approval in different geographies, health payers and systems must listen to the call from global advocates and not place undue obstacles to care – whether that be required biopsy, ambiguous lifestyle requirements, or other hurdles – so that patients are able to access the care they require, no matter who or where they are.”

Recognizing the importance of early detection, a diverse range of partners, including healthcare providers, patient advocacy groups, and community organizations, have joined forces to “Act Now, Screen Today” and launch screening events around the world. From Chile to Nigeria to the Netherlands, the Philippines, and beyond, these events aim to raise awareness, provide education, and offer screening services to individuals at risk of fatty liver disease or the providers who care for them. Global Fatty Liver Day activities are driving positive change at the grassroots level.

“Global Fatty Liver Day is an urgent call-to-action to unite our global efforts to confront the scourge of fatty liver disease,” shares Cat Evans, Director of Program Operations at GLI. “We must act now. By working together, we have the power to create significant change in preventing and managing this pressing health issue through our collaborative efforts.”

Although the challenge of fatty liver disease to the well-being of communities around the globe is great, the power of locally-rooted, collective efforts can turn the tide towards positive change by heightening awareness, equipping people and their healthcare providers with prevention and management tools, expanding understanding of the disease through research, and protecting future liver health through effective policies.

About Global Liver Institute

Global Liver Institute (GLI) is a 501(c)3 nonprofit organization founded in the belief that liver health must take its place on the global public health agenda commensurate with the prevalence and impact of liver illness. GLI promotes innovation, encourages collaboration, and supports the scaling of optimal approaches to help eradicate liver diseases. Operating globally, GLI is committed to solving the problems that matter to liver patients and equipping advocates to improve the lives of individuals and families impacted by liver disease. Follow GLI on FacebookInstagramLinkedIn, and YouTube, or visit www.globalliver.org. GLI is the host of Global Fatty Liver Day.

Christine Maalouf
Global Liver Institute
cmaalouf@globalliver.org

GlobeNewswire Distribution ID 9153607

From Awareness to Action on Global Fatty Liver Day

Global Liver Institute Unites the Field in Times of Name Changes and New Treatments

WASHINGTON, June 13, 2024 (GLOBE NEWSWIRE) — Today marks the seventh annual Global Fatty Liver Day (formerly International NASH Day), led by Global Liver Institute (GLI) with the theme “Act Now, Screen Today.” This campaign underscores the crucial need for early identification and treatment of fatty liver disease to prevent its progression to chronic liver disease, cirrhosis, or cancer.

Fatty liver disease is now estimated to affect 1 in 3 adults worldwide, and its prevalence is increasing. Fatty liver disease during childhood, once unheard of, is also on the rise. Early detection and timely intervention, whether through lifestyle changes or medical treatments, are essential in stopping and even reversing the progression of the disease. “Act Now, Screen Today” emphasizes that liver health is achievable, but action must begin immediately. Across the globe, partners are driving awareness and educational efforts and ensuring broader access to essential screenings and care.

Global Fatty Liver Day, observed annually on the second Thursday of June, is a rallying cry for collective action to address the growing prevalence of fatty liver disease, the most common liver disease worldwide. “Act Now, Screen Today” reminds everyone that liver health is within reach. Here are specific actions you can take today:

  • Take advantage of liver health screening events happening globally to get assessed for fatty liver disease or schedule a check-up with your doctor, especially if you are managing closely associated metabolic conditions like obesity or diabetes
  • Increase physical activity, as maintaining an active lifestyle can improve liver health
  • Learn about fatty liver disease and its risk factors to take proactive steps towards prevention and management yourself or learn more about the latest research and guidelines for your patients.

With a robust pipeline of pharmaceutical treatments that address diverse mechanisms of action in progress, it is important to identify individuals’ position within the progression of fatty liver disease so that they are poised to receive the most appropriate care possible. Notably, pharmaceutical treatments are available (for certain groups with advanced disease) in two countries, the United States (resmetirom) and India (saroglitazar).

“As a community, we stand at a critical time for the broader global health system to act now to support patients,” shares Donna R. Cryer, JD, Founder and CEO of GLI. “As pharmaceutical treatment options gain approval in different geographies, health payers and systems must listen to the call from global advocates and not place undue obstacles to care – whether that be required biopsy, ambiguous lifestyle requirements, or other hurdles – so that patients are able to access the care they require, no matter who or where they are.”

Recognizing the importance of early detection, a diverse range of partners, including healthcare providers, patient advocacy groups, and community organizations, have joined forces to “Act Now, Screen Today” and launch screening events around the world. From Chile to Nigeria to the Netherlands, the Philippines, and beyond, these events aim to raise awareness, provide education, and offer screening services to individuals at risk of fatty liver disease or the providers who care for them. Global Fatty Liver Day activities are driving positive change at the grassroots level.

“Global Fatty Liver Day is an urgent call-to-action to unite our global efforts to confront the scourge of fatty liver disease,” shares Cat Evans, Director of Program Operations at GLI. “We must act now. By working together, we have the power to create significant change in preventing and managing this pressing health issue through our collaborative efforts.”

Although the challenge of fatty liver disease to the well-being of communities around the globe is great, the power of locally-rooted, collective efforts can turn the tide towards positive change by heightening awareness, equipping people and their healthcare providers with prevention and management tools, expanding understanding of the disease through research, and protecting future liver health through effective policies.

About Global Liver Institute

Global Liver Institute (GLI) is a 501(c)3 nonprofit organization founded in the belief that liver health must take its place on the global public health agenda commensurate with the prevalence and impact of liver illness. GLI promotes innovation, encourages collaboration, and supports the scaling of optimal approaches to help eradicate liver diseases. Operating globally, GLI is committed to solving the problems that matter to liver patients and equipping advocates to improve the lives of individuals and families impacted by liver disease. Follow GLI on FacebookInstagramLinkedIn, and YouTube, or visit www.globalliver.org. GLI is the host of Global Fatty Liver Day.

Christine Maalouf
Global Liver Institute
cmaalouf@globalliver.org

GlobeNewswire Distribution ID 9153607

Adalvo Secures First EU Generic Approval for Liraglutide Pre-Filled Pen

ADALVO LIMITED
Anil Okay, Adalvo CEO, expresses his thoughts on this milestone

SAN ĠWANN, Malta, June 13, 2024 (GLOBE NEWSWIRE) — Adalvo announces the successful DCP approval for Liraglutide pre-filled pen, marking it as the first generic approval in the EU.

As a bioequivalent version of Victoza® pre-filled pen, indicated for the treatment of type 2 diabetes, this peptide drug achieved global sales exceeding $4.8 billion in 2023, as reported by IQVIA.

The successful development of Liraglutide highlights Adalvo’s capability to offer a diverse and comprehensive diabetes portfolio, encompassing both complex peptide injectables and small molecule oral treatments.

Adalvo’s commitment to providing access to high-quality differentiated products while simultaneously navigating manufacturing complexities reinforces Adalvo’s position as a trusted leader in the pharmaceutical industry.

Click Here To View Adalvo’s Diabetes Portfolio

At Adalvo, there are no half-measures – they are always on target. Their mission is to be faster and stronger than their competitors, driving their vision forward with a winning team.

Adalvo is committed to maintaining the highest standards of excellence in all their endeavors and looks forward to continuing to deliver innovative healthcare solutions that make a difference in the lives of patients worldwide.

About Adalvo

Adalvo is a global pharmaceutical company, and one of the leading B2B pharmaceutical companies in Europe, with commercial partnerships in more than 130 countries and over 140 commercial partners globally. The company’s declared purpose is to make a difference for patients all over the world, driven by our smart collaboration network and commitment to delivering the highest quality differentiated products and services to our partners.

Adalvo takes pride in their ability to help partners reach their goals – be those increasing revenues or pushing into new markets. Tirelessly strives for excellence in all of its endeavours, driven by a deep-rooted passion for making a difference for partners.

The company’s purpose-driven culture is committed to improving the lives of patients around the world. Adalvo’s dynamic leadership team brings significant experience and industry know-how, which has helped to establish the company as a reliable global partner in the industry.

Contacts: Gabrielle Cassar, gabrielle.cassar@adalvo.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e1e895aa-f689-4215-a1f8-25285851af9d

GlobeNewswire Distribution ID 1000966220

Nikkiso Clean Energy & Industrial Gases Group Announces CEO Transition July 1, 2024

TEMECULA, Calif., June 13, 2024 (GLOBE NEWSWIRE) — Nikkiso Co., Ltd. (TSE: 6376), announced today after a Board vote, that effective July 1, 2024, Adrian Ridge will succeed Peter Wagner as Nikkiso Clean Energy & Industrial Gases Group’s (part of Nikkiso’s Industrial Division) as Chief Executive Officer. Wagner will stay on in a Board role as Executive Chairman for Nikkiso CE&IG Group.

As CEO, Ridge, who is currently Executive Vice President, Operations and Manufacturing for Nikkiso CE&IG Group, will drive operational and financial results and ready the Group for future growth. Wagner’s new role as Executive Chairman will focus on driving the vision and long-term strategy of the Group in an advisor capacity.

“In six years under Peter’s leadership, Nikkiso CE&IG has more than quadrupled business, and is positioned for strong continued growth,” said Toshihiko Kai, President and CEO, Nikkiso. “I want to thank him for his leadership, and welcome Adrian as the Group’s new CEO.”

Prior to joining Nikkiso in 2018, Wagner was CEO and Managing Director at LEWA Group. Ridge joined Nikkiso in 2022 after approximately 30 years at Atlas Copco serving in various leadership positions.

About Nikkiso Co. Ltd.

Since its establishment in 1953, Nikkiso has contributed to solving social issues by anticipating the changing times with world-first and Japan-first technologies and products. In the industrial business, Nikkiso has created new markets by developing products in the energy field, hemodialysis-related products in the medical business, and CFRP (carbon fiber reinforced plastic) aerostructures in the aerospace business.

About Nikkiso Clean Energy & Industrial Gases Group

The Nikkiso Clean Energy & Industrial Gases Group is a leading provider of cryogenic equipment, technologies and applications for clean energy and industrial gas market segments. The Group employs more than 1,600 people in 22 countries and is headed by Cryogenic Industries, Inc. in Southern California, U.S., which is a wholly owned subsidiary of Nikkiso Co., Ltd. (TSE: 6376).

Media contact
Lisa Adams
+1 405 492 1689

GlobeNewswire Distribution ID 9153273

The Bazaar DC by José Andrés (JF33) Obtains USCIS Project Approval

WASHINGTON, June 12, 2024 (GLOBE NEWSWIRE) — EB5 Capital, a leading EB-5 Regional Center operator, is pleased to report that on May 30, 2024, its restaurant project, The Bazaar DC by José Andrés (JF33), was approved by the United States Citizenship and Immigration Services (USCIS). This Form I-956F approval signifies that USCIS has verified the compliance of JF33, and the individual foreign investors who invested in the project are now closer to obtaining conditional residency in the United States.

The Bazaar DC by José Andrés (JF33) is the development of a 227-seat, approximately 10,000 square-foot, high-end restaurant located in the historic Waldorf Astoria in Washington, DC. EB5 Capital provided a portion of the financing for JF33. The Bazaar DC by José Andrés opened to the public in 2023 and is among 20 EB5 Capital projects in the nation’s capital. In 2019, EB5 Capital also supported the financing of The Ritz-Carlton New York, NoMad, which includes another location of The Bazaar.

EB5 Capital’s JF33 project is owned and managed by José Andrés Group (JAG), a highly reputable and respected restaurant operator based in Washington, DC with nearly 40 restaurant concepts across the United States and internationally, including The Bazaar by José Andrés, barmini, Jaleo, Zaytinya, China Poblano, Oyamel, China Chilcano, in addition to an array of others in its fast-casual division. Sam Bakhshandehpour was recently promoted to Global CEO of the José Andrés Group (JAG), formerly he served as President, and world-famous chef and humanitarian José Andrés, will continue to serve as Founder and Executive Chairman of JAG.

“We would like to congratulate the investors who joined JF33, the first restaurant project in our 40-project portfolio,” said Patrick Rainey, Senior Vice President of Investments at EB5 Capital. “This approval is also a major milestone for our team as it marks our 10ᵗʰ project approved since the EB-5 Reform and Integrity Act of 2022 went into effect.”

EB5 Capital is looking forward to receiving individual I-526E petition approvals from USCIS soon and supporting its investors with the next steps in the immigration process. The firm will continue to identify and execute on EB-5 projects that not only meet the rigorous requirements of USCIS but contribute meaningfully to local communities and economies across the United States.

About EB5 Capital

EB5 Capital provides qualified foreign investors with opportunities to invest in job-creating commercial real estate projects under the United States Immigrant Investor Program (EB-5 Visa Program). Headquartered in Washington, DC, EB5 Capital’s distinguished track record and leadership in the industry has attracted investors from over 75 countries. As one of the oldest and most active Regional Center operators in the country, the firm has raised over $1 billion of foreign capital across approximately 40 EB-5 projects. 100% of our investors’ funds are protected by the Federal Deposit Insurance Corporation (FDIC) insurance prior to their deployment into our projects. Please visit www.eb5capital.com for more information.

Contact:
Katherine Willis
Director, Marketing & Communications
media@eb5capital.com

GlobeNewswire Distribution ID 9152932